Transscatheter aortic valve replacement is a novel way to replace a diseased aortic valve without a median sternotomy. The first human TAVR was performed by Dr. Cribier in 2002. [33] There have ...
With this expansion came a better understanding of associated complications. Spinal cord ischemia, perhaps the most dreaded complication of aortic surgery short of death, led to an understanding of ...
Objective: This study aimed to evaluate the feasibility and initial outcomes of totally endoscopic aortic valve replacement (TEAVR) performed via a single working port at the fourth intercostal space ...
Edwards Lifesciences on Thursday forecast fourth-quarter sales below Wall Street estimates, hurt by softer demand and fierce competition for its artificial heart valves. Investor expectations for ...